Beck Bode LLC Sells 300 Shares of UnitedHealth Group Inc (NYSE:UNH)

Beck Bode LLC lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 18.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,350 shares of the healthcare conglomerate’s stock after selling 300 shares during the period. Beck Bode LLC’s holdings in UnitedHealth Group were worth $293,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Selective Wealth Management Inc. purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $27,000. North Star Investment Management Corp. acquired a new stake in shares of UnitedHealth Group in the third quarter worth $30,000. Delta Asset Management LLC TN raised its stake in shares of UnitedHealth Group by 111.0% during the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 81 shares during the last quarter. Fusion Family Wealth LLC raised its position in UnitedHealth Group by 329.7% during the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 122 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC increased its holdings in shares of UnitedHealth Group by 212.5% during the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 119 shares in the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

NYSE:UNH traded down $3.50 during trading hours on Tuesday, reaching $276.16. 1,055,730 shares of the company traded hands, compared to its average volume of 3,479,326. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94. The stock has a market cap of $265.15 billion, a P/E ratio of 21.44, a P/E/G ratio of 1.48 and a beta of 0.64. The firm’s 50-day moving average is $258.05 and its 200-day moving average is $245.34. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The business had revenue of $60.35 billion for the quarter, compared to analysts’ expectations of $59.84 billion. During the same quarter last year, the firm earned $3.41 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group Inc will post 14.96 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. The ex-dividend date is Friday, December 6th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.56%. UnitedHealth Group’s payout ratio is 33.54%.

In related news, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now directly owns 21,687 shares in the company, valued at approximately $5,531,052.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $232.76, for a total value of $581,900.00. Following the completion of the transaction, the director now directly owns 187,979 shares in the company, valued at $43,753,992.04. The disclosure for this sale can be found here. Insiders sold a total of 38,577 shares of company stock worth $9,398,080 over the last ninety days. Corporate insiders own 0.82% of the company’s stock.

Several research analysts recently weighed in on the stock. Credit Suisse Group set a $293.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Thursday, August 29th. SunTrust Banks reiterated a “buy” rating and set a $335.00 price target (up previously from $310.00) on shares of UnitedHealth Group in a report on Monday, November 18th. UBS Group lowered their price objective on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating for the company in a research report on Thursday, October 17th. Morgan Stanley reaffirmed a “buy” rating and set a $312.00 target price (up previously from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Finally, ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $289.39.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Why does the United States have a lingering trade deficit?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.